A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation

Trial Profile

A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Aug 2017

At a glance

  • Drugs Edoxaban (Primary) ; Prothrombin complex concentrate
  • Indications Embolism; Haemorrhage; Stroke; Venous thromboembolism
  • Focus Adverse reactions
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 16 Aug 2016 Results of this and two other studies published in the British Journal of Clinical Pharmacology.
    • 14 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top